Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Sorrento Therapeutics Inc (SRNE)

Sorrento Therapeutics Inc (SRNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sorrento Therapeutics Inc 4955 DIRECTORS PLACE SAN DIEGO CA 92121 USA

www.sorrentotherapeutics.com P: 858-203-4100

Description:

Sorrento Therapeutics, Inc. is a biopharmaceutical company. It is focused primarily on the acquisition, discovery, development and commercialization of proprietary oncology therapeutics. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and infectious disease. Sorrento Therapeutics, Inc. is based in San Diego, California.

Key Statistics

Overview:

Market Capitalization, $K 441
Enterprise Value, $K 12,231
Shares Outstanding, K 551,281
Annual Sales, $ 62,840 K
Annual Net Income, $ -572,840 K
Last Quarter Sales, $ 15,030 K
Last Quarter Net Income, $ -95,210 K
EBIT, $ -458,150 K
EBITDA, $ -438,110 K
60-Month Beta 1.57
% of Insider Shareholders 2.60%
% of Institutional Shareholders 0.02%
Float, K 536,948
% Float 97.40%
Short Volume Ratio 0.00

Growth:

1-Year Return -96.46%
3-Year Return -99.99%
5-Year Return -99.98%
5-Year Revenue Growth -58.62%
5-Year Earnings Growth -100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 10/04/24
Earnings Per Share ttm -0.63
EPS Growth vs. Prev Year 9.92%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 08/01/13

SRNE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -911.59%
Debt/Equity -0.72
Price/Sales 1.91
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.36
Interest Coverage -64.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar